Tonix Pharmaceuticals Holding (TNXP) EV to FCF (2014 - 2026)

Tonix Pharmaceuticals Holding has reported EV to FCF for 13 years, with the latest figure at 0.93 in Q2 2026.

• On a quarterly basis, EV to FCF rose 90.14% year-over-year to 0.93 in Q2 2026; TTM through Jun 2026 was 0.24, a 89.17% increase from a year earlier, with the FY2025 full-year figure at 0.72, down 41.4% from the prior year.
• EV to FCF was 0.93 for Q2 2026 at Tonix Pharmaceuticals Holding, down from 0.21 in the prior quarter.
• The five-year high for EV to FCF was 5.15 in Q4 2024, with the low at 9.46 in Q2 2025.
• Average EV to FCF over 5 years is 0.48, with a median of 0.43 recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: EV to FCF soared 987.27% in 2024, then tumbled 7336.53% in 2025.
• Over 5 years, EV to FCF stood at 3.95 in 2022, then slumped by 78.84% to 0.84 in 2023, then soared by 516.5% to 5.15 in 2024, then slumped by 65.08% to 1.8 in 2025, then tumbled by 151.86% to 0.93 in 2026.
• The last three EV to FCF figures came in at 0.93 (Q2 2026), 0.21 (Q1 2026), and 1.8 (Q4 2025), per Business Quant data.